Loading evidence-driven research…
Loading evidence-driven research…
Compound Profile
Graviola is safety concerning due to annonaceous acetogenins and neurotoxicity signals; no clinical efficacy evidence supports therapeutic use.
Evidence level
Limited evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Generally well tolerated caution
Best for
Energy
Avoid / review if
Neurotoxicity/Parkinsonism Like Concerns, Mitochondrial Toxicity, No Established Safe Therapeutic Dose.
Review before use if any apply: Neurotoxicity/Parkinsonism Like Concerns, Mitochondrial Toxicity, No Established Safe Therapeutic Dose..
Graviola Annona Muricata has a limited evidence evidence rating.
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
Compare side-by-side tradeoffs or verify active marker guidelines.
Independent database mapping. Sourcing availability is evaluated separately from safety and clinical efficacy scores.
Affiliate Disclosure: Clicking verification or shopping links may earn this site a commission at no additional cost to you. Sourcing links are selected strictly based on quality criteria and availability, never based on commission tiers. Safety warnings and evidence ratings remain independent of sourcing.